與委托方的有效溝通在GLP試驗中的重要性
[Abstract]:As a pharmaceutical outsourcing service industry developed in the past 20 years, GLP industry wants to provide high quality scientific research services to domestic and foreign users while actively promoting the level of business and management of scientific research personnel in institutions. The successful completion of drug safety evaluation test, communication with the client is particularly important, can not be ignored. As the entrustment units, whether they are pharmaceutical factories or general R & D institutions, are not very familiar with the national regulations in the field of GLP and the expertise in drug safety evaluation, therefore, in the early stages of the contract, The entrusted organization should be patient to explain to the entrustment. For larger projects, it is best to communicate face to face so that they can understand some of the regulations and requirements of the GLP. To make them aware of the whole experiment arrangement and what they need to do in the process, including some of the requirements for the test and reference substances they provide, how many tests and standards will be provided and in what form they will be offered, Which information on the test items must be provided, and so on, all of which contribute to the smooth progress of the trials on schedule; during the course of the trials, the entrusted agencies should also take the initiative to report the results and progress of the periodic trials to the entrusting parties in a timely manner. In order for the client to adjust the drug development plan, improve the efficiency of drug development. In the whole process, the entrusted institution should act as a main body to promote effective communication and improve the quality of scientific research services.
【作者單位】: 廣州中醫(yī)藥大學(xué)科技產(chǎn)業(yè)園(新南方藥物安全性評價中心);
【基金】:廣東省科技計劃項目(2012B010300003)
【分類號】:F426.72;F719;R95
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 王女士;;醫(yī)療界與制藥界的有效溝通[J];中國處方藥;2008年09期
2 ;阮永章:有作為才有地位[J];寧波經(jīng)濟(jì)(財經(jīng)視點);2009年03期
3 楊志敏;;企業(yè)界與CDE在新藥研發(fā)中的有效溝通[J];中國處方藥;2010年06期
4 齊顯龍;;“化妝品咨詢醫(yī)師”——一種新職業(yè)?[J];中國激光醫(yī)學(xué)雜志;2010年06期
5 袁曉懋;點擊阿斯利康的并購公關(guān)運作[J];公關(guān)世界;2002年06期
6 沈蕾;;我國醫(yī)藥企業(yè)營銷渠道成員沖突原因及其對策研究[J];中國藥房;2007年10期
7 本刊編輯部;;康泰克PPA危機(jī)公關(guān)典藏[J];醫(yī)藥世界;2007年04期
8 ;[J];;年期
9 ;[J];;年期
10 ;[J];;年期
相關(guān)重要報紙文章 前10條
1 王華鋒;規(guī)范使用藥用輔料 產(chǎn)業(yè)鏈各環(huán)節(jié)須有效溝通[N];中國高新技術(shù)產(chǎn)業(yè)導(dǎo)報;2008年
2 沈菏生;BEM:解決有效溝通問題[N];醫(yī)藥經(jīng)濟(jì)報;2006年
3 李雪墨;頸復(fù)康:居安思危實施戰(zhàn)略創(chuàng)新[N];中國醫(yī)藥報;2007年
4 李志華;感動營銷[N];醫(yī)藥經(jīng)濟(jì)報;2006年
5 馬鑫良;與客戶溝通三原則[N];醫(yī)藥經(jīng)濟(jì)報;2006年
6 何仁;抓住績效管理的三個關(guān)鍵點[N];醫(yī)藥經(jīng)濟(jì)報;2007年
7 范玉蕾邋王娜;石藥集團(tuán) 1-9月出口額達(dá)2億美元[N];石家莊日報;2007年
8 云宏;我的談判經(jīng)[N];醫(yī)藥經(jīng)濟(jì)報;2007年
9 李雪墨;王國治委員提出:疫苗制品應(yīng)協(xié)商供貨[N];中國醫(yī)藥報;2008年
10 記者 張云普邋通訊員 千紅玉;大慶化工集團(tuán)瞄準(zhǔn)目標(biāo)市場開發(fā)新品[N];中國石油報;2008年
,本文編號:2154233
本文鏈接:http://sikaile.net/jingjilunwen/fwjj/2154233.html